48 related articles for article (PubMed ID: 15253555)
1. [Hereditary nonpolyposis colorectal cancer].
Matsukawa M; Yamamoto T; Kouda T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():189-92. PubMed ID: 14574879
[No Abstract] [Full Text] [Related]
2. Hereditary nonpolyposis colorectal cancer identification and surveillance of high-risk families.
Silva RV; Garicochea B; Cotti G; Maranho IC; Cutait R
Clinics (Sao Paulo); 2005 Jun; 60(3):251-6. PubMed ID: 15962087
[TBL] [Abstract][Full Text] [Related]
3. Genetic lesions during progression of hereditary non-polypous colorectal cancer.
Shtam TA; Vostryukhina OA; Gulyaev AV; Pozharissky KM; Lantsov VA
Dokl Biochem Biophys; 2004; 395():69-74. PubMed ID: 15253555
[No Abstract] [Full Text] [Related]
4. Genetic and epigenetic modification of MLH1.
Perucho M
Am J Pathol; 2000 Sep; 157(3):1052-3. PubMed ID: 10980144
[No Abstract] [Full Text] [Related]
5. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of early-onset "sporadic" colorectal cancer with microsatellite instability.
Jass JR
Dis Colon Rectum; 2003 Oct; 46(10):1305-9. PubMed ID: 14530666
[No Abstract] [Full Text] [Related]
7. A novel Q562X mutation identified in the hMLH1 gene in a Slovenian patient with hereditary nonpolyposis colorectal cancer.
Potocnik U; Glavac D; Golouh R; Ravnik-Glavac M
Hum Hered; 2000; 50(2):140-1. PubMed ID: 10799973
[No Abstract] [Full Text] [Related]
8. Decoding hereditary colorectal cancer.
Boland CR
N Engl J Med; 2006 Jun; 354(26):2815-7. PubMed ID: 16807419
[No Abstract] [Full Text] [Related]
9. Mechanisms of tolerance to DNA damaging therapeutic drugs.
Karran P
Carcinogenesis; 2001 Dec; 22(12):1931-7. PubMed ID: 11751422
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype.
Baranovskaya S; Soto JL; Perucho M; Malkhosyan SR
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15107-12. PubMed ID: 11742074
[TBL] [Abstract][Full Text] [Related]
11. Deficient DNA mismatch repair: a common etiologic factor for colon cancer.
Peltomäki P
Hum Mol Genet; 2001 Apr; 10(7):735-40. PubMed ID: 11257106
[TBL] [Abstract][Full Text] [Related]
12. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
[TBL] [Abstract][Full Text] [Related]
13. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Boone CW; Kelloff GJ
Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
[TBL] [Abstract][Full Text] [Related]
14. [Damage to the transforming growth factor TGF-beta type II receptor gene and microsatellite instability in carcinoma cells of the gastrointestinal tract].
Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Kovalev VK; Vasil'ev SV; Pozharisskiī KM; Lantsov VA
Vopr Onkol; 1998; 44(6):667-71. PubMed ID: 10087960
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
